Kiora Pharmaceuticals, Inc.
KPRX
$2.52
$0.031.00%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.08M | -2.42M | -6.52M | 26.80K | -2.15M |
| Total Depreciation and Amortization | 51.50K | 42.00K | 121.70K | 38.20K | 31.50K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 208.10K | 278.40K | 4.57M | -1.43M | 390.10K |
| Change in Net Operating Assets | -72.60K | -1.06M | -354.20K | 87.00K | -2.07M |
| Cash from Operations | -1.89M | -3.16M | -2.18M | -1.27M | -3.80M |
| Capital Expenditure | -23.50K | -5.00K | -78.20K | -400.00 | -32.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -6.87M | 5.41M | 5.43M | 5.74M | 696.40K |
| Cash from Investing | -6.89M | 5.40M | 5.35M | 5.74M | 664.20K |
| Total Debt Issued | -- | -- | 0.00 | 1.75M | 1.00M |
| Total Debt Repaid | -- | -- | 0.00 | -1.75M | -1.00M |
| Issuance of Common Stock | 5.00M | 200.00 | 300.00 | 0.00 | 265.40K |
| Repurchase of Common Stock | -9.30K | -1.00K | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -71.70K | -- | -- | -- | -- |
| Cash from Financing | 4.92M | -800.00 | 300.00 | 0.00 | 265.40K |
| Foreign Exchange rate Adjustments | -16.60K | 20.10K | 18.80K | 13.20K | 131.60K |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | 0.00 | -- |
| Net Change in Cash | -3.88M | 2.26M | 3.19M | 4.48M | -2.74M |